责任不可推卸:围术期脑健康以患者为中心的精准照护使命
围术期是医疗成本的重要驱动因素,也是 largely 可预防的神经损伤来源。术后谵妄影响高达 50-70% 的特定脆弱手术队列,但生理对齐的低成本预防策略常延迟至大型确定性试验支持后才被采用。以患者为中心的精准照护通过 Safe Brain Initiative 结构化框架整合循证方案与真实世界结局验证,从被动治疗转向主动预防在伦理和经济上均必要。
要点
- 术后谵妄在特定脆弱手术队列中影响高达 50-70%,但低成本预防策略采用常被延迟。
- 当前证据等级倒置:反应性高成本治疗证据较弱却常被实施,预防策略需大型试验才被采纳。
- 以患者为中心的精准照护通过 Safe Brain Initiative 框架整合循证方案与真实世界结局验证。
核心结论
- 从被动治疗转向主动预防不仅是伦理要求,也是医疗系统长期可持续的经济必需。
研究设计与样本
- 本文为 Br J Anaesth 发表的评论/观点类文章,未报告原始研究设计或样本量。
主要发现
- 术后谵妄影响高达 50-70% 的特定脆弱手术队列。
- 生理对齐的低成本预防策略常延迟至大型确定性试验支持后才被采用,而反应性高成本治疗在证据较弱时仍常被实施。
- 这种倒置的证据等级制造了有害的经济激励,延续患者伤害与资源利用低效。
临床怎么用
- 围术期脑健康管理应优先采用生理对齐的低成本预防策略,而非等待大型试验后再行动。
- 通过 Safe Brain Initiative 结构化框架整合循证方案与真实世界结局验证,实现以患者为中心的精准照护。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The perioperative period represents both a major driver of healthcare costs and a substantial source of largely preventable neurological harm. Postoperative delirium affects up to 50-70% of specifically vulnerable surgical cohorts, but adoption of physiologically aligned, low-cost preventive strategies is often delayed until supported by large definitive trials. In contrast, reactive and costly treatments are frequently implemented despite weaker evidentiary standards. This inverted evidence hierarchy creates perverse economic incentives that perpetuate patient harm and inefficient resource utilisation. Patient-Centred Precision Care seeks to address this gap by integrating evidence-based protocols with real-world outcome verification through the Safe Brain Initiative's structured framework. Shifting from reactive treatment to proactive prevention is not only ethically imperative, but also economically necessary for the long-term sustainability of healthcare systems.
引用
- Barroso A, Meco BC, Moll V, et al. Responsibility cannot be abdicated: a mandate for Patient-Centred Precision Care in perioperative brain health. Br J Anaesth. 2026. PMID: 41813450. doi:10.1016/j.bja.2026.02.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。